195 related articles for article (PubMed ID: 34917264)
1. Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma.
Scuderi SA; Casili G; Filippone A; Lanza M; Basilotta R; Giuffrida R; Munaò S; Colarossi L; Capra AP; Esposito E; Paterniti I
Oncotarget; 2021 Dec; 12(25):2459-2473. PubMed ID: 34917264
[TBL] [Abstract][Full Text] [Related]
2. KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation.
Scuderi SA; Casili G; Ardizzone A; Forte S; Colarossi L; Sava S; Paterniti I; Esposito E; Cuzzocrea S; Campolo M
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298658
[TBL] [Abstract][Full Text] [Related]
3. Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro.
Cucinotta L; Mannino D; Casili G; Repici A; Crupi L; Paterniti I; Esposito E; Campolo M
Respir Res; 2023 Aug; 24(1):211. PubMed ID: 37626373
[TBL] [Abstract][Full Text] [Related]
4. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
5. The Inhibition of Prolyl Oligopeptidase as New Target to Counteract Chronic Venous Insufficiency: Findings in a Mouse Model.
Casili G; Lanza M; Scuderi SA; Messina S; Paterniti I; Campolo M; Esposito E
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33322134
[TBL] [Abstract][Full Text] [Related]
6. NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression.
Scuderi SA; Casili G; Basilotta R; Lanza M; Filippone A; Raciti G; Puliafito I; Colarossi L; Esposito E; Paterniti I
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681768
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial-Mesenchymal Transition.
Basilotta R; Lanza M; Filippone A; Casili G; Mannino D; De Gaetano F; Chisari G; Colarossi L; Motta G; Campolo M; Cuzzocrea S; Paterniti I; Esposito E
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769105
[TBL] [Abstract][Full Text] [Related]
8. FKBP11 promotes cell proliferation and tumorigenesis via p53-related pathways in oral squamous cell carcinoma.
Qiu L; Liu H; Wang S; Dai XH; Shang JW; Lian XL; Wang GH; Zhang J
Biochem Biophys Res Commun; 2021 Jun; 559():183-190. PubMed ID: 33945996
[TBL] [Abstract][Full Text] [Related]
9. The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion.
Casili G; Scuderi SA; Lanza M; Filippone A; Basilotta R; Mannino D; Campolo M; Esposito E; Paterniti I
Oncotarget; 2021 Aug; 12(17):1663-1676. PubMed ID: 34434495
[TBL] [Abstract][Full Text] [Related]
10. Death by histone deacetylase inhibitor quisinostat in tongue squamous cell carcinoma via apoptosis, pyroptosis, and ferroptosis.
Wang X; Liu K; Gong H; Li D; Chu W; Zhao D; Wang X; Xu D
Toxicol Appl Pharmacol; 2021 Jan; 410():115363. PubMed ID: 33290780
[TBL] [Abstract][Full Text] [Related]
11. Cantharidin inhibits cell proliferation and promotes apoptosis in tongue squamous cell carcinoma through suppression of miR-214 and regulation of p53 and Bcl-2/Bax.
Tian X; Zeng G; Li X; Wu Z; Wang L
Oncol Rep; 2015 Jun; 33(6):3061-8. PubMed ID: 25962755
[TBL] [Abstract][Full Text] [Related]
12. The growth inhibitory effect of human gingiva-derived mesenchymal stromal cells expressing interferon-β on tongue squamous cell carcinoma cells and xenograft model.
Du L; Liang Q; Ge S; Yang C; Yang P
Stem Cell Res Ther; 2019 Jul; 10(1):224. PubMed ID: 31358054
[TBL] [Abstract][Full Text] [Related]
13. Guanylate-binding protein 6 is a novel biomarker for tumorigenesis and prognosis in tongue squamous cell carcinoma.
Liu PF; Chen HC; Shu CW; Sie HC; Lee CH; Liou HH; Cheng JT; Tsai KW; Ger LP
Clin Oral Investig; 2020 Aug; 24(8):2673-2682. PubMed ID: 31707626
[TBL] [Abstract][Full Text] [Related]
14. A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease.
Myöhänen TT; Hannula MJ; Van Elzen R; Gerard M; Van Der Veken P; García-Horsman JA; Baekelandt V; Männistö PT; Lambeir AM
Br J Pharmacol; 2012 Jun; 166(3):1097-113. PubMed ID: 22233220
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Myosin 6 inhibits proliferation of oral squamous cell carcinoma cells.
Zhang X; Huang Z; Hu Y; Liu L
J Oral Pathol Med; 2016 Nov; 45(10):740-745. PubMed ID: 27561828
[TBL] [Abstract][Full Text] [Related]
16. Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines.
Weng J; Wang C; Wang Y; Tang H; Liang J; Liu X; Huang H; Hou J
Oral Oncol; 2014 Oct; 50(10):983-90. PubMed ID: 25096824
[TBL] [Abstract][Full Text] [Related]
17. Safflower polysaccharide inhibits the development of tongue squamous cell carcinoma.
Zhou H; Yang J; Zhang C; Zhang Y; Wang R; Li X; Zhang S
World J Surg Oncol; 2018 Aug; 16(1):167. PubMed ID: 30103745
[TBL] [Abstract][Full Text] [Related]
18. Experimental oral carcinoma of the tongue and buccal mucosa: possible biologic markers linked to cancers at two anatomic sites.
Schwartz JL; Gu X; Kittles RA; Baptiste A; Shklar G
Oral Oncol; 2000 Mar; 36(2):225-35. PubMed ID: 10745177
[TBL] [Abstract][Full Text] [Related]
19. The in vitro and in vivo antitumor effects of clotrimazole on oral squamous cell carcinoma.
Wang J; Jia L; Kuang Z; Wu T; Hong Y; Chen X; Leung WK; Xia J; Cheng B
PLoS One; 2014; 9(6):e98885. PubMed ID: 24892421
[TBL] [Abstract][Full Text] [Related]
20. UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma.
Liu PF; Chen CF; Shu CW; Chang HM; Lee CH; Liou HH; Ger LP; Chen CL; Kang BH
Diagnostics (Basel); 2020 Sep; 10(9):. PubMed ID: 32899896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
